Pharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pharmaceutical stocks.

Pharmaceutical Stocks Recent News

Date Stock Title
May 20 TLPH Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 20 VVOS Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified Directors
May 18 VVOS Vivos Therapeutics, Inc. (VVOS) Q1 2024 Earnings Call Transcript
May 18 OPTN OptiNose, Inc. (OPTN) Q1 2024 Earnings Call Transcript
May 17 OPTN Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 16 TLPH Talphera to Participate at A.G.P. Virtual Healthcare Conference
May 15 POAI Predictive Oncology Inc. (POAI) Q1 2024 Earnings Call Transcript
May 15 VVOS Vivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
May 15 DNA Ginkgo slips as BTIG cuts to Sell on strategic shift
May 15 VVOS Vivos Therapeutics GAAP EPS of -$1.63, revenue of $3.4M
May 15 POAI Predictive Oncology GAAP EPS of -$1.04, revenue of $0.42M
May 15 DNA Ginkgo Bioworks to Participate in Two Conferences in May
May 15 POAI Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
May 15 OPTN Q1 2024 OptiNose Inc Earnings Call
May 15 OPTN OptiNose Inc (OPTN) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Financial ...
May 14 TLPH Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript
May 14 DNA Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan
May 14 TLPH AcelRx Pharmaceuticals GAAP EPS of -$0.16 beats by $0.06
May 14 TLPH Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 14 VVOS Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
Pharmaceutical

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags